16 zincage rink-1

Upload: rachmady

Post on 09-Apr-2018

214 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/8/2019 16 Zincage Rink-1

    1/28

    Zinc-altered immune function

    Lothar Rink

    Institute of ImmunologyUniversity Hospital

    RWTH Aachen University

  • 8/8/2019 16 Zincage Rink-1

    2/28

    University Hospital Aachen

  • 8/8/2019 16 Zincage Rink-1

    3/28

    Decreased parameters of the immunesystem during zinc deficiency

    Thymocyte and T cell counts and proliferation

    Delayed-type hypersensitivity reaction

    Cytotoxic (CTL) and T-helper (Th) cell-functions

    Antibody production

    NK cell activity

    Macrophage functions (phagocytosis, killing)

    Neutrophil functions (oxygen burst,chemotaxis)

  • 8/8/2019 16 Zincage Rink-1

    4/28

    Contents1. Direct effects of zinc on leukocytes

    2. Modulation of the immune response by zinc

    in vitro and in vivo

    3. Zinc-uptake

  • 8/8/2019 16 Zincage Rink-1

    5/28

    TNF- RT-PCR of PBMC

    -actin

    TNF-

    123bpladder

    0 Zn Co Ni Hg LPS

  • 8/8/2019 16 Zincage Rink-1

    6/28

    Cytokine production by PBMC

    C o n t r

    o l

    Cation conentration

    % o

    f z i n c -

    i n d u c e

    d c y

    t o k i n e s

  • 8/8/2019 16 Zincage Rink-1

    7/28

    Contents1. Direct effects of zinc on leukocytes

    2. Modulation of the immune response by zinc

    in vitro and in vivo

    3. Zinc-uptake

  • 8/8/2019 16 Zincage Rink-1

    8/28

    Indirect T cell stimulation

    Control Zinc Control Zinc

    w/oseparation with separation

    C y t o

    k i n e

    c o n c e n t r a

    t i o n

  • 8/8/2019 16 Zincage Rink-1

    9/28

    Inhibition of IL-1 dependentT-cell proliferation

  • 8/8/2019 16 Zincage Rink-1

    10/28

    Inhibition of IL-1 receptor-associatedkinase activity by zinc

  • 8/8/2019 16 Zincage Rink-1

    11/28

    Zinc inhibits the IFN- production

    in the MLC

  • 8/8/2019 16 Zincage Rink-1

    12/28

    Zinc inhibits the MLC comparable toCyclosporin A

    MLC MLC MLC MLC CsA50M zinc 100M zinc

    I F N -

    ( p g / m

    l )

    0

    200

    400

    600

    800

    1000

    ***

    n = 16

  • 8/8/2019 16 Zincage Rink-1

    13/28

    Zinc intake inhibits alloreactivity in everydonor combination

    before after

    zinc intake

    I F N -

    ( p g

    / m

    l )

    0

    200

    400

    600

    800

    1000

    1200

    1400

    1600

    *

    =

  • 8/8/2019 16 Zincage Rink-1

    14/28

    Reconstitution of IFN production by zinc

  • 8/8/2019 16 Zincage Rink-1

    15/28

    Contents1. Direct effects of zinc on leukocytes

    2. Modulation of the immune response by zinc

    in vitro and in vivo

    3. Zinc-uptake

  • 8/8/2019 16 Zincage Rink-1

    16/28

    Zinc uptake in peripheral blood

    mononuclear cells

  • 8/8/2019 16 Zincage Rink-1

    17/28

    Zinc uptake

    PBMC monocytes T cells f l u o r e s c e n c e

    i n c r e a s e

    ( %

    o f c o n

    t r o l )

  • 8/8/2019 16 Zincage Rink-1

    18/28

    Complete zinc uptake

    Zinc mg/l

    Whole blood PBMC in SF PBMC in RPMI + FCS

    Control

    5min 0.1 mM

    1h 0.1 mM

  • 8/8/2019 16 Zincage Rink-1

    19/28

    Influence of zinc on B cells in vivo

    Apoptosis Apoptosis

    Deficiency

    Normal

    Physiological normal

    Highzincdosages

    B cell functions

    Serum zinc concentration

  • 8/8/2019 16 Zincage Rink-1

    20/28

    Influence of zinc on monocytes in

    vivo

    Deficiency

    Physiologicalnormal

    High zinc dosagesabove

    Monocyte/Macrophage functions

    Serum zinc concentration

    Normal

    ApoptosisDecreased

    30 M 100 M

    NormalDirect

    activation

  • 8/8/2019 16 Zincage Rink-1

    21/28

    Influence of zinc on T cells in vivo

    DeficiencyPhysiologicalnormal

    High zinc dosagesabove

    T cell functions

    Serum zinc concentration

    Normal

    Apoptosis Apoptosis

    Increased auto- andalloreactivity

    Decreased

    Suppressed

    30 M 100 M

  • 8/8/2019 16 Zincage Rink-1

    22/28

    Expression of hZIPs in Leukocytes

    0

    0,5

    1

    1,5

    2

    2,5

    3

    3,5

    hZip1-THP hZip2-THP hZip3-THP hZip1-RAJI hZip2-RAJI hZip3-RAJI hZip1-JURKAT

    hZip2-JURKAT

    hZip3-JURKAT

    x-fold Expression

  • 8/8/2019 16 Zincage Rink-1

    23/28

    Regulation of hZIPs inTHP monocytes

    0

    0,5

    1

    1,5

    2

    2,5

    3

    3,5

    4

    4,5

    5

    hZip1 hZip2 hZip3 hZip1-15Zn

    hZip2-15Zn

    hZip3-15Zn

    hZip1-30Zn

    hZip2-30Zn

    hZip3-30Zn

    hZip1-2,5TPEN

    hZip2-2,5TPEN

    hZip3-2,5TPEN

    x-fold Expressio n

  • 8/8/2019 16 Zincage Rink-1

    24/28

    Regulation of hZIPs in Jurkat T cells

    0

    0,5

    1

    1,5

    2

    2,5

    3

    3,5

    4

    4,5

    hZip1 hZip2 hZip3 hZip1-15Zn

    hZip2-15Zn

    hZip3-15Zn

    hZip1-30Zn

    hZip2-30Zn

    hZip3-30Zn

    hZip1-1,0TPEN

    hZip2-1,0TPEN

    hZip3-1,0TPEN

    x-fold Expressio n

  • 8/8/2019 16 Zincage Rink-1

    25/28

    Regulation of hZIPs inRaji B cells

    0

    5

    10

    15

    20

    25

    30

    35

    40

    45

    hZip1 hZip2 hZip3 hZip1-15Zn

    hZip2-15Zn

    hZip3-15Zn

    hZip1-30Zn

    hZip2-30Zn

    hZip3-30Zn

    hZip1-2,5TPEN

    hZip2-2,5TPEN

    hZip3-2,5TPEN

    x-fold Expressio n

  • 8/8/2019 16 Zincage Rink-1

    26/28

    Conclusions

    Only zinc induces cytokine transcription Zinc blocks some T cell functions

    Zinc enhances monocyte response Zinc reconstitutes decreased IFN- production of

    elderly Zinc enters the cells within minutes

    Zinc transporters are different in leukocyte subsets

  • 8/8/2019 16 Zincage Rink-1

    27/28

    Perspectives

    Zinc prophylaxis in elderly or other zinc-deficient patients

    Zinc therapy in T cell-dependentdiseases

  • 8/8/2019 16 Zincage Rink-1

    28/28

    Zinc Projects

    Immunology Internal Medicine Nele Wellinghausen Burkhard KreftClaudia MetzPhilip Gabriel PharmacologyIrem Cakman Michael U. Martin

    Christian Faber Klaus-Helge Ibs Gerontology

    Hajo Haase Rudolf-M. Schtz